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Chemiluminescence technique as a novel detection method has gained much attention in recent years owning to
the merits of high sensitivity, wider linear ranges, and low background signal. Similarly, nanotechnology especially
for gold nanoparticles has emerged as detection tools due to their unique physical and chemical properties. Recently,
it has become increasingly popular to couple gold nanoparticles with chemiluminescence technique in biological
agents’ detection. In this review, we describe the superiority of both chemiluminescence and gold nanoparticles and
conclude the different applications of gold nanoparticle-initialed chemiluminescence in biomedical detection.
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Introduction
Detection of biological agents plays an indispensable role
in biomedicine [1]. In clinical diagnosis, developing
highly sensitive and cost-effective detection methods is
in high demand for the reason that some clinical sam-
ples have very low concentration that usually cannot be
detected. Since the advent of radioimmunoassay (RIA)
[2], the trace materials could be detected. From then,
detection technologies have gained much attention and
a few techniques were developed, including fluoroimmu-
noassay (FIA) and enzyme immunoassay (EIA). The FIA
and EIA were regularly used but sometimes cannot meet
the clinical demand due to their low sensitivities. The
RIA is characterized by great sensitivity but has some
drawbacks, including health hazard, short half-life, and
environment contamination [3].
In the late 1970s, chemiluminescence immunoassay
(CLIA) was first introduced [4]. The mechanism of
chemiluminescence (CL) is that some molecules can get
the energy from the chemical reaction and be excited to
the electronically excited state; the energy is disposed of
in the form of light along with the molecules return to* Correspondence: zezhongliu@yeah.net; changhuiyun@126.com
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the Creative Commons license, and indicate ifground state [5]. It does not need photoluminescence
and the energy comes from chemical interaction, which
leads to low background signal [6, 7]. In addition, it also
has some merits including ultrasensitivity, high signal-
to-noise ratio, low cost, and wide linear dynamic ranges
[8, 9]. All of those advantages make CL to be a powerful
detection method.
Nanobiotechnology is the product of biology and
nanotechnology, which develops rapidly and shows a
significant future promise [10]. Almost all the areas of
biomedicine such as bioimaging [11, 12], drug delivery
[13, 14], oncotherapy [15, 16], and clinical diagnosis [17]
have the shadow of nanomaterials. Among the nanoma-
terials including magnetic nanoparticles, quantum dots,
graphene oxide, carbon nanotubes, and gold nanoparti-
cles (AuNPs), the AuNP is the most widely used.
Nanotechnology, especially for AuNPs, which offers a
wealth of particular characteristics suited for diagnosis, has
becoming a promising strategy to enhance the CL sensitiv-
ity. In recent years, the CL detection method based on
AuNPs has continuously emerged. The detection limit and
detection time has been improved extremely. This AuNP-
initialed CL detection method has been applied in different
fields such as for detection and diagnosis of microorganism,
protein, nucleic acids, pharmaceutical molecules, and so
many small molecules (Fig.1). This review surmises the
superiority and the preparation method of AuNPs andis distributed under the terms of the Creative Commons Attribution 4.0
rg/licenses/by/4.0/), which permits unrestricted use, distribution, and
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Fig. 1 Examples of CL based on AuNPs for detection of biomolecules
Liu et al. Nanoscale Research Letters  (2016) 11:460 Page 2 of 8concludes the general strategies of CL based on AuNPs for
detection of biomolecules.
The Outstanding Features of AuNPs
AuNPs have some physical, chemical, optical, and electrical
attributes [18] (Fig.2).
(i) Easy synthesis and synthetic versatility: AuNPs could
be made in precise control over shape (sphere, rod,
nanoshell, nanostar, triangular, nanocage) and size
(1–150 nm) [15, 19–21]. The properties of AuNPs
can be tuned by regulating the diameter and the
shape because different shape and size has its
distinct features [22, 23]. Therefore, we can make
the right AuNPs to satisfy the applications at hand.
(ii)Surface functionality: the biocompatibility of AuNPs
is excellent. Thiols and amines could bind to the
surface of AuNPs so as to provide a facile way for
some active group such as protein, biotin, peptide,
and nucleic acids to conjugate with AuNPs by the
chemistry of thiol-gold, gold-amine, or electrostatic
interactions [24–26].(iii)Chemical inert: AuNPs are essentially inert and do
not cause acute cytotoxicity [27].
(iv)Catalytic performance: AuNPs, the diameter vary
from 6 to 99 nm especially for 38 nm, can catalyze
the system of luminol-H2O2 [28]. In addition, it
also can directly catalyze the system of AgNO3-
luminol.
(v)Optical properties: surface plasmon resonance
(SPR) could detect the changes in nanoparticle
aggregation states [29]. The color of dispersed
AuNP solution appears red, while the aggregate
solution appears blue for the reason that SPR
shows the absorption maximum at longer
wavelength, which is known as red-shift. If the
size and the shape of AuNPs have changed, the
peak of absorbance would be correspondingly
changed.
(vi)Small size and high surface area to volume ratios:
AuNPs could be loaded with plenty of biological
reagents, and it can be made rather small so as to
provide a high surface area to volume ratio, which
maximize the payload/carrier ratio [29, 30].
Fig. 2 The unique attributes of AuNPs
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AuNPs can be synthesized by reduction of HAuCl4. The
methods include chemical reduction, irradiation reduction
[31, 32], sonochemical reduction [33], and biochemistry
reduction [34, 17]. The most common way is the chemical
reduction. In this reduction system, there must be redu-
cing agent to reduction HAuIIICl4 to Au
0 (10–150 nm)
[35] and capping agent to bind to the surface of AuNPs
with the purpose of controlling the size and inhabiting
particle aggregation. The reducing agents include sodium
citrate, sodium borohydride (NaBH4), and diborane. The
corresponding capping agents are citrate, alkanethiol, and
phosphine [36]. Among various synthesis methods for
AuNPs, the method of citrate reduction is most widely
used and the procedure is as followed (Fig. 3).The Strategies of CL Based on Labeling AuNPs
The CL detection methods based on AuNPs have two
approaches: (i) AuNPs are directly used as catalyst to
amplify CL signal. (ii) The detection signal is amplified
by the biomolecules loading on the surface of AuNPssuch as antibody, horseradish peroxidase (HRP), luminol,
and biotin. The strategies are depicted as followed (Fig. 4).
In conventional CL detection, the AuNPs were dissolved
with the solution of NaCl-HCl-Br2 to form AuCl4
−, which
could catalyze luminol to initial CL reaction. However,
each AuNP contains thousands of gold atoms, and the
NH2OH can catalyze AuNPs to form gold atoms. In such
a condition, more AuCl4
− can be formed in NaCl-HCl-Br2
solution, leading to a high catalyze ability. Zhang et al.
[37] developed a gold(III)-enhanced CLIA for detection of
porcine circovirus (PCV). It was demonstrated that the
detection signal could be further enhanced by NH2OH
amplification assay so that the detection limit was lowered
to 2.67 × 102 copies mL−1.
The dissolution of AuNPs must be conducted under
extremely severe conditions, which need a long time and
complex operations, leading to a high CL background
signal. Li et al. [38] used silver deposition on gold labels
for detection of human immunoglobulin G (IgG). Although
the sensitivity was further elevated, time-consuming was
also a big drawback. Afterwards, non-stripping CL was de-
veloped, and it can shorten detection time greatly, which
Fig. 3 Reduction of HAuCl4 with sodium citrate in water: the sizes of AuNPs are depended on the concentration of sodium citrate
Liu et al. Nanoscale Research Letters  (2016) 11:460 Page 4 of 8attracts researcher’s interests. Wang et al. [39] found that
irregular AuNPs have a stronger catalytic efficiency than
spherical AuNPs, but the complicated synthesis processes
restrict its clinical application. Subsequently, luminol-
AgNO3-AuNPs CL system was developed [40]. The mech-
anism of this system is that luminol is a reducing agent for
reduction of AgNO3 to Ag atom; meanwhile, luminol was
oxidized to luminol radicals under the catalysis of AuNPs.
So, the normal spherical AuNPs could catalyze luminol to
produce CL in the presence of AgNO3. According to this
condition, Luo et al. [41] found an interesting phenomenon
that the dispersed AuNPs can catalyze luminol-AgNO3 to
produce a weak CL, while the aggregated AuNPs can pro-
duce a strong CL. Based on this finding, they developed a
homogenous CLIA for determination of human IgG. The
antibody-functionalized AuNPs could aggregate along with
the immunoreaction of antigen and antibody, and the CL
signal is enhanced obviously owing to the high catalytic ac-
tivity of aggregated AuNPs. This method omitted washing
and separation steps; the detection limit of IgG is as low as
3 pg mL−1.
Zhou et al. [42] developed a CL method using HRP
and detection antibody-coated AuNPs as nanoprobes for
detection of antibody against porcine parvovirus (PPV).
After the nanoprobes captured the primary antibody, the
solution of luminol and H2O2 were added immediately.
The CL signal is amplified extremely because there are
lots of HRP on the surface of AuNPs. In this assay,
standard positive serum at the 1:1024 dilutions was still
detected. Yang et al. [43] developed a CLIA detection
method for α-fetoprotein (AFP) utilizing double-codified
gold nanoparticles (DC-AuNPs) as probe and 4-(4-iodo)-
phenylphenol (IPP) as enhancer. The primary anti-AFPantibody was immobilized on the surface of magnetic
beads (MB), and the AuNP was conjugated with both
anti-AFP antibody and HRP. First, the antigen was cap-
tured with functional magnetic beads, and then, the
immunocomplex were recognized by the DC-AuNPs.
The detection limit is as low as 5 pg mL−1.
Yang et al. [44] developed a CLIA for detection of
carcinoembryonic antigen based on AuNPs. The assay
coimmobilizes not only secondary antibody but also
luminol onto the AuNPs. 3-MPA was used as a linker to
connect with AuNPs via sulfur-gold bond firstly, and
then, the secondary antibody and luminol was conjugated
with 3-MPA. Magnetic beads were used as carriers to
loading primary antibody. HRP and Co3+ were used as cat-
alysts. The detection limit for CEA is as low as 5.0 × 10−11
and 1.0 × 10−10 gmL−1 correspondingly.
The coimmobilization antibody and luminol onto the
surface of AuNPs result in a lower CL signal than luminol
free in the solution, which attributes to the change in
charge, steric hindrance accessibility, and the structure of
luminol. In order to overcome this drawback, Shourian
et al. [45] replaced antibodies with biotin to immobilization
on the surface of AuNPs. The AuNP-biotin-luminol and
AuNP-antibody-luminol system were compared, and the
results showed that the former signal was 12 times higher
than the latter, because the antibody occupied most of the
surface and restricted the connection of luminol. On the
contrary, the size of biotin is so small that luminol could
attach to the AuNPs sufficiently. They applied biotin-
streptavidin reaction in CLIA based on AuNPs for detec-
tion of hepatitis B surface antigen. The assay loading biotin
and luminol molecule on the surface of AuNPs and the
secondary antibody was modified with streptavidin. After
Fig. 4 The strategies of CL based on labeling AuNPs
Liu et al. Nanoscale Research Letters  (2016) 11:460 Page 5 of 8secondary antibody recognized the primary antibody,
the biotin-luminol-AuNPs would bond to the immu-
nocomplex by the reaction of biotin-streptavidin.
Streptavidin is a tetrameric protein so that more than
one biotin molecule would bond to it. In addition, thebinding constant of biotin-streptavidin is high and the
complex has a high stability in a wide pH and
temperature. All of these benefits make this system a
very high-sensitivity assay, with a detection limit of
0.358 pg mL−1 for hepatitis B surface antigen.
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AuNPs
Labeling biomolecules such as antibody, HRP, and luminol
are very troublesome. Therefore, label-free AuNP-initialed
CL detection method was developed recently (Fig. 5).
Regularly, in the aqueous solution of AuNPs, there
must be capping agents to inhibit the aggregation of
nanoparticles. But in 2004, an interesting phenomenon
that a certain concentration salt can screen the repulsion
between AuNPs and make aggregation of them was
reported [46]. The aggregated AuNPs could initial a stron-
ger CL than dispersed in the system of luminol-H2O2.
Based on these findings, Islam and Kang [47] developed a
label-free CL method for detection of C-reactive protein
(CRP). The ligand of CRP is O-phosphorylethanolamine
(PEA), which has a distinct property that can stick to the
surface of gold so that it can inhibit the aggregation of
AuNPs in the presence of salt and initial a weak CL. Once
the reaction of CRP-PEA happened, the AuNPs would
aggregate and show a strong CL signal. This CL method
does not require labeling and strict stripping procedures;
the detect limit is as low as 1.88 fM.
Qi et al. [48] developed a label-free DNA hybridization
method based on the AuNP-initialed CL. The principle
is that AuNPs could not aggregate in the presence of
single-strand DNA (ss-DNA) probe and 0.5 M NaCl for
the reason that ss-DNA absorb onto the surface of
AuNPs and inhibit the aggregation of them. After the
target DNA was added, the ss-DNA probe would be re-
moved by the reaction of hybridization, leading to the
aggregation of AuNPs and making a stronger CL. The
detection limit is as low as 1.1 fM.Fig. 5 The strategies of label-free CL based on AuNPsIn a similar vein, Zhang et al. [49] developed a label-
free CL method for detection of fibrillar fibrin. The
fibrinogen could absorb on the surface of AuNPs and in-
hibit the aggregation of nanoparticles in the presence of
1 M NaCl. After thrombins catalyze fibrinogen to fibril-
lar fibrin, the AuNPs would aggregate and initial a stron-
ger CL. Based on this principle, the limit of detection for
fibrin was as low as 1 fM.
In the system of luminol-H2O2, some active groups such
as −NH2, −SH could struggle for active oxygen intermedi-
ates with luminol, making the decrease of CL signal [28].
Liu et al. [50] found that L-cys could also inhibit the CL of
luminol-H2O2-AuNP system. Therefore, they integrate
laminated paper-based analytica device (LPAD) with
AuNP-catalyzed CL method for determination of L-cys.
This detection system not only has the superiority of LAPD
such as low cost and suitable for point of care (POC) but
also has the high sensitivity of CL. The detection limit is as
low as 8.2 × 10−10 M.
CLIA Based on AuNPs Couple with Separation Technique
It seems that the usual CLIA has multifarious washing
and separating steps, which is time-consuming and
sophisticated. Recently, capillary electrophoresis (CE),
high-performance liquid chromatography (HPLC), and
flow injection (FI) coupled with CLIA have attracted
great interests for the merits of high separation effi-
ciency, ease of automation, and time-saving. Jiang et al.
[51] combined CE with AuNP-amplified CL to detection
of carcinoembryonic antigen (CEA). The CEA antibody
and HRP were also conjugated with AuNPs. After the
nanoprobes recognized the antigen, the excess AuNP
Liu et al. Nanoscale Research Letters  (2016) 11:460 Page 7 of 8conjugates were separated by the CE, and the CL was
activated by the p-iodophenol (PIP)-enhanced luminol-
H2O2-HRP system. The detection process could be
finished within 5 min, and the detection limit is as low
as 0.034 ng mL−1. Liu et al. [52] proposed a novel
protocol for detection of protein by means of aptamer-
functionalized AuNPs and CE-CL. Taking thrombin as
a model, they linked thrombin-binding aptamer to the
AuNPs by the SH–Au covalent bond and blocked the
spare binding side with blocker DNA. After CE sepa-
rated, luminol and H2O2 were added. The detection
limit is down to 13.5 fmol L−1.
Li et al. [53] found that some reductive compounds
such as monoamine neurotransmitters and their metab-
olites have an inhibitory effect on the luminol-AgNO3-
AuNPs. These reductive compounds have a stronger re-
ductive ability than luminol, and competed with lumi-
nol for AgNO3, making that the generation of luminol
radicals is decreased and leading to a weak CL signal.
By taking advantage of this phenomenon, they devel-
oped a CL method for simultaneous determination of
monoamine neurotransmitters and their metabolites in
a mouse brain microdialysate. HPLC was applied in this
system, and the method was simple, sensitive, and fast.
Hao and Ma [54] combined FI system with AuNP-
enhanced CL to detection of carcinoembryonic antigen
(CEA). They loaded the secondary antibody onto the
surface of AuNPs and utilized the method of dissolving
AuNPs into HNO3-HCl solution. The detection limit is
as low as 20 pg mL−1.
Conclusions
CL as the newest labeling technique has been widely
applied in biomedical diagnosis during the two decade.
Nanodiagnostic techniques especially for AuNPs have
gained much attention by the researchers. Coupling
both techniques to detection of biological agents is a
trend in the last several years. Continuous efforts for
labeling biomarkers (e.g. proteins, genes, and chemilu-
minescent agent) onto the surface of AuNPs are made
so as to improve the sensitivity of CL. The labeling
strategies are improving constantly, and the detection
limit is becoming lower. In addition, the separation
technique and the label-free strategies are also devel-
oped quickly because it can simplify the operation and
save more time. All of these efforts are to develop
rapid, sensitive, automatic, and point of care detection
methods. Currently, some new and readily contagious
viruses such as Zika virus, Ebola virus, and avian influ-
enza virus, which could pose a great disaster for hu-
man, have not been detected in a quick and sensitive
way. If the CL based on AuNP detection method could
be developed for those virus detection, the significance
for public health would be important. In the next20 years, the CL based on AuNP detection method
would become the most widely used detection method
in clinical medicine and clinical veterinary science.
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